Medindia

X

Misonix To Present at The Rodman & Renshaw 10th Annual Healthcare Conference

Tuesday, November 4, 2008 General News J E 4
Advertisement
FARMINGDALE, N.Y., Nov. 3 Misonix, Inc. (Nasdaq: MSON), a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of cancer and worldwide for other acute health conditions, today announced that Michael A. McManus, Jr., President and Chief Executive Officer, will present at the Rodman & Renshaw 10th Annual Healthcare Conference to be held on November 10-12 at the New York Palace Hotel in New York City.



Mr. McManus is scheduled to present on Wednesday, November 12, 2008 at 3:15 p.m. ET. The presentation will be accessible via live webcast at http://www.wsw.com/webcast/rrshq14/mson and will also be archived on the Misonix website for a period of 90 days. For more information on the conference please visit the conference website http://www.rodm.com/conferences?id=19.



About Misonix:

Misonix, Inc. (Nasdaq: MSON) designs, develops, manufactures and markets therapeutic ultrasonic medical devices and laboratory equipment. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.



SOURCE Misonix, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NeoStem Signs Definitive Agreement to Acquire Cont...
S
Gold's Gym Members Outvote The Governator; Vote Ba...